Inari Medical Inc. (NARI)
Inari Medical Statistics
Share Statistics
Inari Medical has 58.56M shares outstanding. The number of shares has increased by 1.01% in one year.
Shares Outstanding | 58.56M |
Shares Change (YoY) | 1.01% |
Shares Change (QoQ) | 0.48% |
Owned by Institutions (%) | 93.59% |
Shares Floating | 53.34M |
Failed to Deliver (FTD) Shares | 1 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 2.35M, so 4.01% of the outstanding shares have been sold short.
Short Interest | 2.35M |
Short % of Shares Out | 4.01% |
Short % of Float | 4.65% |
Short Ratio (days to cover) | 0.54 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 304.2. Inari Medical's PEG ratio is undefined.
PE Ratio | undefined |
Forward PE | 304.2 |
PS Ratio | 7.47 |
Forward PS | 4.2 |
PB Ratio | 7.93 |
P/FCF Ratio | undefined |
PEG Ratio | undefined |
Enterprise Valuation
Inari Medical has an Enterprise Value (EV) of 3.68B.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of undefined.
Current Ratio | 3.09 |
Quick Ratio | 2.52 |
Debt / Equity | undefined |
Debt / EBITDA | - |
Debt / FCF | - |
Interest Coverage | undefined |
Financial Efficiency
Return on Equity is 0% and Return on Invested Capital is 1.09%.
Return on Equity | 0% |
Return on Assets | 0% |
Return on Invested Capital | 1.09% |
Revenue Per Employee | $379.72K |
Profits Per Employee | $-1.26K |
Employee Count | 1,300 |
Asset Turnover | 0.73 |
Inventory Turnover | 1.38 |
Taxes
Income Tax | 5.88M |
Effective Tax Rate | 1.39% |
Stock Price Statistics
The stock price has increased by 41.87% in the last 52 weeks. The beta is 1.03, so Inari Medical's price volatility has been higher than the market average.
Beta | 1.03 |
52-Week Price Change | 41.87% |
50-Day Moving Average | 68.49 |
200-Day Moving Average | 52.58 |
Relative Strength Index (RSI) | 79.6 |
Average Volume (20 Days) | 2.34M |
Income Statement
In the last 12 months, Inari Medical had revenue of 493.63M and earned -1.64M in profits. Earnings per share was -0.03.
Revenue | 493.63M |
Gross Profit | 434.56M |
Operating Income | -14.03M |
Net Income | -1.64M |
EBITDA | 15.19M |
EBIT | -14.03M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 38.6M in cash and 32.05M in debt, giving a net cash position of 6.55M.
Cash & Cash Equivalents | 38.6M |
Total Debt | 32.05M |
Net Cash | 6.55M |
Retained Earnings | -48.49M |
Total Assets | 697.24M |
Working Capital | 114.61M |
Cash Flow
In the last 12 months, operating cash flow was 35.93M and capital expenditures -6.2M, giving a free cash flow of 29.73M.
Operating Cash Flow | 35.93M |
Capital Expenditures | -6.2M |
Free Cash Flow | 29.73M |
FCF Per Share | 0.52 |
Margins
Gross margin is 88.03%, with operating and profit margins of -2.84% and -0.33%.
Gross Margin | 88.03% |
Operating Margin | -2.84% |
Pretax Margin | 0.86% |
Profit Margin | -0.33% |
EBITDA Margin | 3.08% |
EBIT Margin | -2.84% |
FCF Margin | 6.02% |
Dividends & Yields
NARI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -0.04% |
FCF Yield | 0.63% |
Analyst Forecast
Currently there are no analyst rating for NARI.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 11.23 |
Piotroski F-Score | 2 |